In a study now published in Microbiology Spectrum, a team of Vancouver investigators, led by Dr. Agatha Jassem of the British Columbia Center for Disease Control (BCCDC) and partially funded by the CITF, demonstrated that dried blood spot (DBS) testing should be considered reliable in detecting SARS-CoV-2 seropositivity acquired from both natural infection and vaccination.